Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

ABSTRACT:

Disclaimer

This article is based on recommendations from the 12^th WALT Congress, Nice, October 3-6, 2018, and a follow-up review of the existing data and the clinical observations of an international multidisciplinary panel of clinicians and researchers with expertise in the area of supportive care in cancer and/or PBM clinical application and dosimetry. This article is informational in nature. As with all clinical materials, this paper should be used with a clear understanding that continued research and practice could result in new insights and recommendations. The review reflects the collective opinion and, as such, does not necessarily represent the opinion of any individual author. In no event shall the authors be liable for any decision made or action taken in reli

SUBMITTER: Robijns J 

PROVIDER: S-EPMC9468822 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature